Thomasville National Bank Sells 411,340 Shares of CVS Health Co. (NYSE:CVS)

Thomasville National Bank trimmed its position in CVS Health Co. (NYSE:CVS) by 94.6% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 23,274 shares of the pharmacy operator’s stock after selling 411,340 shares during the period. Thomasville National Bank’s holdings in CVS Health were worth $1,463,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of CVS. Ables Iannone Moore & Associates Inc. bought a new stake in shares of CVS Health during the 4th quarter worth $32,000. First Community Trust NA lifted its holdings in shares of CVS Health by 116.2% during the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after acquiring an additional 302 shares during the last quarter. Creekmur Asset Management LLC bought a new stake in shares of CVS Health during the 4th quarter worth $34,000. Steph & Co. lifted its holdings in shares of CVS Health by 192.0% during the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after acquiring an additional 288 shares during the last quarter. Finally, ORG Partners LLC lifted its holdings in shares of CVS Health by 11,840.0% during the 2nd quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock worth $35,000 after acquiring an additional 592 shares during the last quarter. 80.66% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the stock. Wells Fargo & Company lifted their price objective on shares of CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a report on Monday, August 12th. Evercore ISI boosted their price target on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 8th. Barclays raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $63.00 to $82.00 in a research note on Thursday. Royal Bank of Canada reissued an “outperform” rating and issued a $68.00 price target on shares of CVS Health in a research note on Wednesday, September 4th. Finally, TD Cowen raised shares of CVS Health from a “hold” rating to a “buy” rating and boosted their price target for the stock from $59.00 to $85.00 in a research note on Friday, October 4th. Nine research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $75.26.

CVS Health Price Performance

CVS stock opened at $66.63 on Monday. CVS Health Co. has a 1 year low of $52.77 and a 1 year high of $83.25. The company has a market cap of $83.65 billion, a P/E ratio of 11.71, a PEG ratio of 0.93 and a beta of 0.54. The firm has a 50-day moving average of $59.12 and a 200 day moving average of $60.89. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.73 by $0.10. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The company had revenue of $91.23 billion during the quarter, compared to the consensus estimate of $91.41 billion. During the same period in the prior year, the firm earned $2.21 earnings per share. CVS Health’s revenue was up 2.6% on a year-over-year basis. On average, sell-side analysts forecast that CVS Health Co. will post 6.51 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Shareholders of record on Monday, October 21st will be issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.99%. The ex-dividend date is Monday, October 21st. CVS Health’s dividend payout ratio (DPR) is presently 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.